Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Litton Mark James
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-22
Sale
2022-06-24
7:51 pm
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
7,960$2.69$21,412148,244
(Indirect
Direct)
View
2018-06-01
Sale
2018-06-05
5:40 pm
ALDER BIOPHARMACEUTICALS INCALDRLitton Mark James
Chief Business Officer
22,727$17.84$405,412180,189
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-27
Option Award
2023-01-31
7:33 pm
N/A
2033-01-26
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
425,000$0573,906
(Direct)
View
2023-01-27
Option Award
2023-01-31
7:33 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
662$2.74573,906
(Direct)
View
2022-06-22
Option Award
2022-06-24
7:51 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
757$7.06148,244
(Direct)
View
2022-06-22
Option Award
2022-06-24
7:51 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
20,000$0148,244
(Direct)
View
2022-01-27
Option Award
2022-01-31
5:06 pm
N/A
2032-01-26
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
400,000$0535,447
(Direct)
View
2022-01-27
Option Award
2022-01-31
5:06 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Executive Officer
885$12.51535,447
(Direct)
View
2021-08-17
Exercise
2021-08-19
5:05 pm
N/A
2029-08-14
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
50,440$0235,442
(Direct)
View
2021-08-17
Exercise
2021-08-19
5:05 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
50,440$1.35235,442
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:05 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
867$14.45235,442
(Direct)
View
2021-02-18
Option Award
2021-02-22
5:36 pm
N/A
2031-02-17
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
85,000$085,000
(Direct)
View
2020-09-22
Conversion
2020-09-22
5:15 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
32,815$070,129
(Direct)
View
2020-09-17
Ownership
2020-09-17
8:32 pm
N/A
N/A
Athira Pharma Inc.ATHALitton Mark James
Chief Operating Officer
0$0281,232
(Direct)
View
2019-02-06
Option Award
2019-02-08
4:30 pm
N/A
2028-08-05
ALPINE IMMUNE SCIENCES IncALPNLitton Mark James
See Remarks
100,000$0100,000
(Direct)
View
2018-08-06
Option Award
2018-08-08
6:34 pm
N/A
2028-08-05
ALPINE IMMUNE SCIENCES IncALPNLitton Mark James
See Remarks
150,000$0150,000
(Direct)
View
2018-06-01
Exercise
2018-06-05
5:40 pm
N/A
2019-04-20
ALDER BIOPHARMACEUTICALS INCALDRLitton Mark James
Chief Business Officer
22,727$0180,189
(Direct)
View
2018-06-01
Exercise
2018-06-05
5:40 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INCALDRLitton Mark James
Chief Business Officer
22,727$0.99180,189
(Direct)
View
2018-02-16
Option Award
2018-02-21
5:31 pm
N/A
2028-02-15
ALDER BIOPHARMACEUTICALS INCALDRLitton Mark James
Chief Business Officer
75,000$075,000
(Direct)
View